Table 3 Clinical and treatment characteristics of patients with carotid blow-out syndrome
Patient number | SBRT scheme | GTV volume (ml) | SBRT site | Dose of primary radiotherapy (Gy) | SBRT dose (Gy)/fx number | Maximum carotid artery point dose (Gy) | Local control |
|---|---|---|---|---|---|---|---|
1 | I | 157 | Hypopharynx | 60 | 30/5 | 41.8 | Complete response |
2 | I | 173 | Retromolar trigone | 60 | 35/5 | 59 | Progression |
3 | I | 130 | Larynx | 60 | 30/5 | 39.4 | Complete response |
4 | I | 29 | Nasopharynx | 70 | 35/5 | 46.6 | Partial response |
5 | I | 101 | Nasopharynx | 66 | 30/5 | 38.5 | Complete response |
6 | I | 37 | Nasopharynx | 65 | 30/5 | 37.5 | Progression |
7 | I | 50 | Nasopharynx | 66 | 32/5 | 40.7 | Stabile |
8 | II | 55 | Nasopharynx | 66 | 32/6 | 46 | Partial response |
9 | II | 127 | Larynx | 70 | 30/5 | 37.5 | Stabile |
10 | II | 30 | Hypopharynx | 64 | 30/5 | 41 | Stabile |
11 | II | 51 | Oral cavity | 70 | 30/5 | 38.5 | Stabile |